RX and M&A at atypical firm thoughts?

Hi,
Just wondering what you think about being in an RX, Special Situations, and M&A Advisory group at a relatively new (non-investment) firm on street (think something like a consulting firm..etc.) I have an offer for a summer internship with a new arm of the firm where I will sit on the IB RX group. Do you think this will provide a good experience and could learn a lot relative to other top firms in the field (HL,PJT, Evercore?)

11 Comments
 

starts with an h right. take it but they don't have a ton of deal flow 

 

No H either. I mean honestly I understand naming the firm is highly relevant, they work in the MM, but rather I’m just wondering if being in that group alone, no matter what firm, is going to provide a good experience relative to other rx shops or even traditional IB at MM firms? I find restructuring really interesting and am just curious if gaining exposure to that regardless of the firm will be a good experience or look good?

 
Most Helpful

this is a pointless post lmao there is zero downside to this. RX is RX. I've seen a kid at a tier 4 shop lateral into a tier1/tier2 Rx seat after 1 year ft from a low semi target background . It's also a trial run to see if you are cut out to pursue it full time. 

 

Neque nihil ut nihil iure quae aperiam voluptates cupiditate. Aperiam ut qui qui iste. Molestiae enim deleniti ut dolorem omnis nam voluptatem.

Dicta eaque omnis dolorem delectus. Quos ad temporibus voluptates sint laboriosam nesciunt reiciendis. Autem corporis itaque quia. Molestias deserunt nulla illum cum voluptatem animi ipsa.

Numquam et itaque et. Dolore iste vel ut dolores temporibus. Ullam inventore enim sed maiores qui et expedita est.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
DrApeman's picture
DrApeman
98.9
7
GameTheory's picture
GameTheory
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
dosk17's picture
dosk17
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”